Journal of Cardiac Failure

Article	Citations
Universal Definition and Classification of Heart Failure	436
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure	215
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America	191
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure	93
Sex Differences in Heart Failure	89
Economic Issues in Heart Failure in the United States	67
Heart Failure-Related Cardiogenic Shock: Pathophysiology, Evaluation and Management Considerations	62
Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors	58
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary	58
Metabolomic Profile in HFpEF vs HFrEF Patients	57
Trends in Heart Failure Hospitalizations in the US from 2008 to 2018	51
Hemodynamics for the Heart Failure Clinician: A State-of-the-Art Review	48
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry	48
Racial and Ethnic Disparities Persist in the Current Era of Pediatric Heart Transplantation	44
Right Ventricular Dysfunction Is Common and Identifies Patients at Risk of Dying in Cardiogenic Shock	42
Myocardial Ketones Metabolism in Heart Failure	42
Lactate Clearance Is Associated With Improved Survival in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Prognostic Factor Studies	41
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review	40
A Clinician's Guide to the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure	39
Sacubitril/Valsartan Initiation and Postdischarge Adherence Among Patients Hospitalized for Heart Failure	37
Vagus Nerve Stimulation Provides Multiyear Improvements in Autonomic Function and Cardiac Electrical Stability in the ANTHEM-HF Study	36
Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) – Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure	35
Risk Prediction in Cardiogenic Shock: Current State of Knowledge, Challenges and Opportunities	35
Misdiagnosis of Heart Failure: A Systematic Review of the Literature	34
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials	33

Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study	33
The Effect of Decongestion on Intrarenal Venous Flow Patterns in Patients With Acute Heart Failure	32
Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry	32
Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience	31
Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy	31
Effects of Depression on Heart Failure Self-Care	31
Arterial Stiffness and Vascular Load in HFpEF: Differences Among Women and Men	31
Prognostic Impact of Changes in Intrarenal Venous Flow Pattern in Patients With Heart Failure	30
Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation	30
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?	29
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population	28
Cognitive Decline and Risk of Dementia in Individuals With Heart Failure: A Systematic Review and Meta-analysis	27
The V-LAP System for Remote Left Atrial Pressure Monitoring of Patients With Heart Failure	26
Practices of Referring Patients to Advanced Heart Failure Centers	26
Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System	25
Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America	25
Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial	25
Self-care Management Intervention in Heart Failure (SMART-HF): A Multicenter Randomized Controlled Trial	25
Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart Failure	25
Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool	24
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry	24
The Association Between Socioeconomic Status, Sex, Race / Ethnicity and In-Hospital Mortality Among Patients Hospitalized for Heart Failure	24
Impact of Right Atrial Remodeling in Heart Failure With Preserved Ejection Fraction	24
Pulmonary Artery Catheter Use and Risk of In-hospital Death in Heart Failure Cardiogenic Shock	23
Pregnancy after Heart Transplantation	23
Discordance of Pressure and Volume: Potential Implications for Pressure-Guided Remote Monitoring in Heart Failure	23
Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan	23
Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry	23
Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF	22
Dynamic Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure After Left Ventricular Assist Device	22
Prominent Longitudinal Strain Reduction of Basal Left Ventricular Segments in Patients With Coronavirus Disease-19	22
The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure	22
Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent	22
Predicting 30-Day Readmissions in Patients With Heart Failure Using Administrative Data: A Machine Learning Approach	21
Characteristics of Elderly Patients with Heart Failure and Impact on Activities of Daily Living: A Registry Report from Super-Aged Society	21
Assessment of Myocardial Fibrosis Using Two-Dimensional and Three-Dimensional Speckle Tracking Echocardiography in Dilated Cardiomyopathy With Advanced Heart Failure	21
Interleukin-6 and Outcomes in Acute Heart Failure: An ASCEND-HF Substudy	21
Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure–Volume Analysis	21
The Impact of Health Care Disparities on Patients With Heart Failure	20
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results	20
Building a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America	20
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of A	20
Wearable Patch-Based Estimation of Oxygen Uptake and Assessment of Clinical Status during Cardiopulmonary Exercise Testing in Patients With Heart Failure	20
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience	19
Iron Deficiency Is Associated With Impaired Biventricular Reserve and Reduced Exercise Capacity in Patients With Unexplained Dyspnea	19
H2FPEF Score Reflects the Left Atrial Strain and Predicts Prognosis in Patients With Heart Failure With Preserved Ejection Fraction	19
Socioeconomic Deprivation and Heart Failure Mortality in the United States	19
Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis	19
Long-term Risk of Death and Hospitalization in Patients With Heart Failure and Takotsubo Syndrome: Insights From a Nationwide Cohort	18
Empagliflozin in Heart Failure With Predicted Preserved Versus Reduced Ejection Fraction: Data From the EMPA-REG OUTCOME Trial	18

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial	18
Fatigue in Persons With Heart Failure: A Systematic Literature Review and Meta-Synthesis Using the Biopsychosocial Model of Health	18
Association between Respiratory Failure and Clinical Outcomes in Patients with Acute Heart Failure: Analysis of 5 Pooled Clinical Trials	18
Representativeness of the VICTORIA Trial Population in Clinical Practice: Analysis of the PINNACLE Registry	17
Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death	17
Acute Unloading Effects of Sildenafil Enhance Right Ventricular–Pulmonary Artery Coupling in Heart Failure	17
Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes	17
Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis	16
Diuresis-Related Weight Loss Reflects Interstitial Compartment Decongestion with Minimal Impact on Intravascular Volume Expansion or Outcomes in Post-Acute Heart Failure	16
Temporal Trends in Post Myocardial Infarction Heart Failure and Outcomes Among Older Adults	16
Physiology and Clinical Utility of HeartMate Pump Parameters	16
Resting Heart Rate as an Important Predictor of Mortality and Morbidity in Ambulatory Patients With Heart Failure: A Systematic Review and Meta-Analysis	16
Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction	16
Possible Association Between Body Temperature and B-Type Natriuretic Peptide in Patients With Cardiovascular Diseases	16
Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United States	16
Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure	16
Atrial Fibrillation, Thromboembolic Risk, and Anticoagulation in Cardiac Amyloidosis: A Review	16
Sustained Reduction in Pulmonary Artery Pressures and Hospitalizations During 2 Years of Ambulatory Monitoring	16
Biomarkers and Their Relation to Cardiac Function Late After Peripartum Cardiomyopathy	16
Pregnancy Associated Heart Failure With Preserved Ejection Fraction: Risk Factors and Maternal Morbidity	16
Hospitalization for Heart Failure in the United States, UK, Taiwan, and Japan: An International Comparison of Administrative Health Records on 413,385 Individual Patients	15
HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support	15
Relationship Between Soluble Transferrin Receptor and Clinical Outcomes in Patients With Heart Failure According to Ejection Fraction Phenotype: The New Zealand PEOPLE Study	15
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support	15
Intra-aortic Balloon Pump for Acute-on-Chronic Heart Failure Complicated by Cardiogenic Shock	15
Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial	15
Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer	15
Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America	15
The Potential Roles of Osmotic and Nonosmotic Sodium Handling in Mediating the Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Heart Failure	15
Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Arterial Stiffness and Abnormal Left Ventricular Hemodynamic Responses During Exercise	15
Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action From the HELP Trial	15
Bariatric Surgery in Patients with Obesity and Ventricular Assist Devices Considered for Heart Transplantation: Systematic Review and Individual Participant Data Meta-analysis	15
PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates	15
Drugs of Abuse and Heart Failure	14
Cultivating Interest in Heart Failure Careers: Can We Reverse the Current Trend?	14
Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review	14
Multidisciplinary Care in Heart Failure Services	14
Left Atrial Stiffness Index Independently Predicts Exercise Intolerance and Quality of Life in Older, Obese Patients With Heart Failure With Preserved Ejection Fraction	14
Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial	14
Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure	14
National Trends in the Use of Sacubitril/Valsartan	14
Associations of Angiopoietins With Heart Failure Incidence and Severity	14
Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3	13
Cystatin C and Muscle Mass in Patients With Heart Failure	13
Characterization of the Progression From Ambulatory to Hospitalized Heart Failure With Preserved Ejection Fraction	13
Acute Hemodynamic Effects of Sacubitril-Valsartan In Heart Failure Patients Receiving Intravenous Vasodilator and Inotropic Therapy	13
Right Ventricular Pressure–Volume Analysis During Left Ventricular Assist Device Speed Optimization Studies: Insights Into Interventricular Interactions and Right Ventricular Failure	13
Sex and Race Differences in Cardiac Sarcoidosis Presentation, Treatment and Outcomes	13
Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study	13
Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure	13
Impact of Mental Stress and Anger on Indices of Diastolic Function in Patients With Heart Failure	13
Increased Opportunities for Transplantation for Women in the New Heart Allocation System	13
The Road Not Yet Traveled: Distinction in Critical Care Cardiology through the Advanced Heart Failure and Transplant Cardiology Training Pathway	13
Prognostic Understanding and Preference for the Communication Process with Physicians in Hospitalized Heart Failure Patients	13
Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning	12
Outcomes and Predictors of Mortality Among Cardiac Intensive Care Unit Patients With Heart Failure	12
Epidemiology of Worsening Heart Failure in a Population-based Cohort from Alberta, Canada: Evaluating Eligibility for Treatment With Vericiguat	12
Standardization of the Right Heart Catheterization and the Emerging Role of Advanced Hemodynamics in Heart Failure	12
Hemodynamic Aberrancies in Left Ventricular Assist Device–Associated Heart Failure Syndromes	12
Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency	12
Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience	12
Estimation of Stressed Blood Volume in Patients With Cardiogenic Shock From Acute Myocardial Infarction and Decompensated Heart Failure	12
Patient-centered Outcomes in HFrEF Following a Worsening Heart Failure Event: A Survey Analysis	12
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review	12
Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial	12
Comparison of Soluble ST2, Pentraxin-3, Galectin-3, and High-Sensitivity Troponin T of Cardiovascular Outcomes in Patients With Acute Decompensated Heart Failure	12
Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-Day Readmission	11
Implementing Nonphysician Provider Guideline-Directed Medical Therapy Heart Failure Clinics: A Multi-National Imperative	11
Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind Study	11
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event	11
Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience	11
Cardiac Transplantation in Danon Disease	11
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure	11
Ten-Year Risk-Prediction Equations for Incident Heart Failure Hospitalizations in Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort Study and the Multi-Ethnic Study of Ather	11
Transition to Advanced Therapies in Elderly Patients Supported by Extracorporeal Membrane Oxygenation Therapy	11
EXPANDing the Donor Pool: Quantifying the Potential Impact of a Portable Organ-Care System for Expanded Criteria Heart Donation	11
Universal Definition and Classification of Heart Failure: Is It universal? Does It Define Heart Failure?	11
Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014–2018 Medical Expenditure Panel Survey	11
Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction	11
The Association of Digital Health Application Use With Heart Failure Care and Outcomes: Insights From CONNECT-HF	11

A Roadmap to Reinvigorating Training Pathways Focused on the Care of Patients With Heart Failure: Shifting From Failure to Function	11
Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry	11
The Cost-Effectiveness of Palliative Care: Insights from the PAL-HF Trial	10
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging	10
Quality of Heart Failure Care in the Intensive Care Unit	10
Practical Patient Care Considerations With Use of Vericiguat After Worsening Heart Failure Events	10
Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial	10
Enhanced Recovery After Surgery in Patients Implanted with Left Ventricular Assist Device	10
Hand Grip Strength Predicts Mortality and Quality of Life in Heart Failure: Insights From the Singapore Cohort of Patients With Advanced Heart Failure	10
Direct Assessment of Muscle Sympathetic Nerve Activity During Exercise in Heart Failure With Preserved Ejection Fraction: A Case Report	10
Soluble ST2 and Diuretic Efficiency in Acute Heart Failure and Concomitant Renal Dysfunction	10
Impact of Socioeconomic Status on Outcomes After Ventricular Assist Device Implantation Using the Area Deprivation Index	10
Person with Heart Failure and Care Partner Dyads: Current Knowledge, Challenges, and Future Directions: State-of-the-Art Review	10
A Randomized Controlled Trial of Mobile Health Intervention in Patients With Heart Failure and Diabetes	10
Risk Prediction for Peripartum Cardiomyopathy in Delivering Mothers: A Validated Risk Model	10
Association of Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure	10
Outcomes in Patients With Chronic Kidney Disease and End-stage Renal Disease and Durable Left Ventricular Assist Device: Insights From the United States Renal Data System Database	9
Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome	9
Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction	9
Palliative Care for Patients With Heart Failure: Results From a Heart Failure Society of America Survey	9
Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure	9
Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction	9
Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis	9
Health-Related Quality of Life Is a Mediator of the Relationship Between Medication Adherence and Cardiac Event-Free Survival in Patients with Heart Failure	9
Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network	9
Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome	9
Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis	9
Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA)	9
Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction	9
The Differential Impact of the Left Atrial Pressure Components on Pulmonary Arterial Compliance–Resistance Relationship in Heart Failure	9
Innovations in Heart Transplantation: A Review	9
Effects of Low-Level Tragus Stimulation on Endothelial Function in Heart Failure With Reduced Ejection Fraction	9
Delirium Among Hospitalized Older Adults With Acute Heart Failure Exacerbation	9
Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart Failure	9
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine	9
Active B-Type Natriuretic Peptide Measured by Mass Spectrometry and Response to Sacubitril/Valsartan	9
The Intersection of Heart Failure and Critical Care: The Contemporary Cardiac Intensive Care Unit and the Opportunity for a Unique Training Pathway	9
Combining Iron Supplements With SGLT2 Inhibitor-Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events?	9
Role of Internal Jugular Venous Ultrasound in suspected or confirmed Heart Failure: A Systematic Review	8
Pregnancy With a Ventricular Assist Device: A Systematic Review of the Existing Literature	8
Predicting Long-Term Mortality in Patients With Acute Heart Failure by Using Machine Learning	8
Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population	8
In-Hospital Serum Uric Acid Change Predicts Adverse Outcome in Patients With Heart Failure	8
The Additive Prognostic Value of Serial Plasma Interleukin-6 Levels over Changes in Brain Natriuretic Peptide in Patients with Acute Heart Failure	8
Full-Time Cardiac Intensive Care Unit Staffing by Heart Failure Specialists and its Association with Mortality Rates	8
The HEART Camp Exercise Intervention Improves Exercise Adherence, Physical Function, and Patient-Reported Outcomes in Adults With Preserved Ejection Fraction Heart Failure	8
Association of Midlife Cardiovascular Risk Factors With the Risk of Heart Failure Subtypes Later in Life	8
Contemplation from Our Hearts: A Call to Shift From Failure to Function	8
Safety of Contemporary Heart Failure Therapy in Patients with Continuous-Flow Left Ventricular Assist Devices	8
Missense Genetic Variation of ICAM1 and Incident Heart Failure	8
An Interprofessional Collaborative Practice Can Reduce Heart Failure Hospital Readmissions and Costs in an Underserved Population	8
Outpatient Management of Guideline-Directed Medical Therapy for Heart Failure Using Telehealth: A Comparison of In-Office, Video, and Telephone Visits	8
Prevalence, Temporal Change, and Determinants of Anxiety and Depression in Hospitalized Patients With Heart Failure	8
Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device	8
Medical Treatment of Heart Failure: Ignore the Ejection Fraction and Treat All?	8
Prior Carpal Tunnel Syndrome and Early Concomitant Echocardiographic Findings Among Patients With Cardiac Amyloidosis	8
Elevated AT1R Antibody and Morbidity in Patients Bridged to Heart Transplant Using Continuous Flow Left Ventricular Assist Devices	8
Cardiac Xenotransplantation: Rebirth Amidst an Uncertain Future	8
Health System–Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial	8
Outcomes in Patients With LVADs Undergoing Simultaneous Heart-Kidney Transplantation	8
Exposure to Elevated Nitrogen Dioxide Concentrations and Cardiac Remodeling in Patients With Dilated Cardiomyopathy	8
Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction	8
Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure	8
Postdischarge Functional Capacity, Health-Related Quality of Life, Depression, Anxiety, and Post-traumatic Stress Disorder in Patients Receiving a Long-term Left Ventricular Assist Device	7
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test	7
The Relationship Between Valproate and Lamotrigine/Levetiracetam Use and Prognosis in Patients With Epilepsy and Heart Failure: A Danish Register-Based Study	7
Randomized Controlled Trial of a Cognitive Intervention to Improve Memory in Heart Failure	7
Making the Case for an Expanded Indication for Sacubitril/Valsartan in Heart Failure	7
Relationship of Vascular Endothelial Growth Factor C, a Lymphangiogenesis Modulator, With Edema Formation, Congestion and Outcomes in Acute Heart Failure	7
Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials	7
Safety and Treatment Experience With Sodium/glucose Cotransporter-2 Inhibitors in Adult Patients With Congenital Heart Disease	7
Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives	7
Transcatheter Left Ventricular Restoration in Patients With Heart Failure	7
Heart Failure in Patients Undergoing Elective and Emergency Noncardiac Surgery: Still a Poorly Addressed Risk Factor	7
Exploring Physician Perceptions of the 2018 United States Heart Transplant Allocation System	7
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial	7
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4	7
Patient stratification for risk of readmission due to heart failure by using nationwide administrative data	7
Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States	7
Outcomes of Patients Transferred to Tertiary Care Centers for Treatment of Cardiogenic Shock: A Cardiogenic Shock Working Group Analysis	7
Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation	7
Contemporary Nationwide Heart Transplantation and Left Ventricular Assist Device Outcomes in Patients with Histories of Bariatric Surgery	7
Contemporary Management of Cardiogenic Shock During Pregnancy	7
Combination Biomarkers for Risk Stratification in Patients With Chronic Heart Failure Biomarkers Prognostication in HF	7
The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study	6
A Stepwise Guide to the Diagnosis and Treatment of Heart Failure With Preserved Ejection Fraction	6
Plasma Volume Status and Its Association With In-Hospital and Postdischarge Outcomes in Decompensated Heart Failure	6
Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation	6
Emerging Implantable-Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care	6
Multiple Cardiac Biomarker Testing Among Patients With Acute Dyspnea From the ICON-RELOADED Study	6
HCV-Positive Allograft Use in Heart Transplantation Is Associated With Increased Access to Overdose Donors and Reduced Waitlist Mortality Without Compromising Outcomes	6
The Quiet Place	6
Association of Perceived Stress With Incident Heart Failure	6
Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community	6
Rate Versus Rhythm Control in Heart Failure Patients with Post-Operative Atrial Fibrillation After Cardiac Surgery	6